Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Fluorescein for Ureteral Visualization During Hysterectomy
NCT02971800Completed
- Sponsor
- CHU de Québec-Université Laval
- Start
- Aug 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fluorescein, sponsored by CHU de Québec-Université Laval. Primary endpoints: Quality of Ureteral Efflux Coloration With Sodium Fluorescein at 15 minutes and Adverse Reaction Related to Sodium Fluorescein Injection at 2 months. Started Aug 2016; status: completed.
02
Drugs
fluorescein
Beyond the preview
Go deeper on NCT02971800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02971800.